Sign Up for FORCE
Newsletters
Read about cancer treatment options listed by gene mutation, type of cancer and type of treatment.
Read about cancer treatment options listed by gene mutation, type of cancer and type of treatment.
Cancer Treatment > Biomarker Testing > Common Biomarker Tests
Biomarkers used for treatment selection
The following tumor biomarkers may be used to select treatment for the cancer types listed below. Speak with your doctor about other tests and treatments, which may be available.
Cancer | Treatment/s | |||||||
---|---|---|---|---|---|---|---|---|
Breast | Colorectal | Endometrial | Melanoma | Ovarian | Pancreatic |
|
||
BRAFV600E | X | X |
Braftovi (encorafenib) |
|||||
, | X | X | Lynparza (olaparib) Rubraca () Zejula® () |
|||||
Epidermal growth factor receptor (EGFR) mutation testing |
X |
Erbitux (cetuximab) |
||||||
Estrogen/Progesterone receptor (ER/PR) expression |
X | X |
Aromatase inhibitors (AIs) |
|||||
Her2neu overexpression | X | X | X | Herceptin (trastuzumab) Perjeta (pertuzumab) Tuksya (tucatinib) Kadcyla (ado-trastuzumab emtansine) |
||||
Deficiency () |
X |
Lynparza (olaparib) |
||||||
Response (HRR) pathway mutations (, , , , , CDK12, , FANCL, , RAD51B, , , RAD54) | X | Lynparza (olaparib) | ||||||
KRAS mutation | X |
Erbitux (cetuximab) |
||||||
MSI-H () or dMMR/MMR-D (Mismatch Repair Deficient) | X | X | X | X | X | X | X | Keytruda (pembrolizumab) |
MSI-H () or dMMR/MMR-D (Mismatch Repair Deficient) | X | Opdivo (nivolumab) Yervoy (ipilimumab) |
||||||
dMMR/MMR-D (Mismatch Repair Deficient) | X | Jemperli (dostarlimab) | ||||||
NTRK fusion | X | X | X | X | X | X | X | Vitrakvi (larotrectinib) |
PDL1 expression | X | Tecentriq (atezolizumab) | ||||||
PIK3CA | X | Piqray (alpelisib), | ||||||
(TMB) | X | X | X | X | X | X | X | Keytruda (pembrolizumab) |
Last updated January 22, 2022